Key Takeaways
- DKNG shares declined approximately 10% Wednesday, settling near $22.52 with exceptionally light trading volume—82% below typical levels
- Senate betting legislation interpreted as unfavorable by investors sparked a significant selloff
- NCAA filed legal action against DraftKings seeking to prevent use of “March Madness” and related trademarks amid tournament peak
- Company recently lowered 2026 revenue projections to $6.5–6.9B, missing analyst expectations by more than $600M
- Wall Street maintains “Moderate Buy” rating with consensus target price of $37.09, representing substantial upside from current trading levels
Shares of DraftKings (DKNG) are hovering around $22.52 Wednesday following a steep decline of approximately 10%.
The Wednesday selloff stems from a dual set of challenges confronting the sports betting giant. Market participants interpreted recent Senate betting legislation as detrimental to DraftKings’ business model, while simultaneously the NCAA initiated legal proceedings aimed at preventing the company from utilizing tournament-associated intellectual property including “March Madness.”
The NCAA’s legal timing presents significant operational complications. Filing during the tournament season—historically among the most profitable periods for sports wagering platforms—poses risks to promotional strategies and near-term financial performance. Potential marketing restrictions or court-ordered injunctions could materially impact revenue generation.
Trading activity Wednesday registered just over 2.8 million shares, representing an 82% decline compared to the 15.6 million average session volume. Such dramatically reduced liquidity can exacerbate price volatility in both directions.
This represents the latest challenge for DKNG in 2026. Earlier this year, executives projected annual revenue between $6.5–6.9 billion, falling more than $600 million below analyst consensus estimates. The stock experienced a mid-teens percentage decline following that disclosure and has faced continued selling pressure.
Revenue Outlook Disappoints Despite Stellar 2025 Performance
The guidance reduction proved particularly disappointing considering the robust Q4 2025 results. Revenue reached approximately $1.99 billion, representing 43% year-over-year growth. Adjusted EBITDA more than tripled to roughly $620 million for the complete fiscal year, while the company achieved positive net income for the first time in its history.
DraftKings accomplished what shareholders had long anticipated—profitability—before tempering future expectations. This contrasting message fundamentally altered the company’s growth story entering 2026.
Shares currently trade significantly beneath both the 50-day moving average of $26.39 and the 200-day moving average of $32.01, underscoring the persistent downward momentum since the guidance adjustment.
From a competitive positioning perspective, DraftKings has pursued aggressive pricing strategies. Analysis conducted during March Madness revealed DKNG offering the industry’s most favorable average vigorish among major operators on money-line and total wagers. While this approach maintains customer retention, it simultaneously pressures profit margins.
Analyst Community Remains Constructive Despite Target Reductions
The investment community continues supporting the stock. Among thirty-two analysts covering DKNG, twenty-five recommend Buy, five suggest Hold, and two advise Sell. The consensus twelve-month price objective stands at $37.09—representing over 60% appreciation potential from Wednesday’s levels.
Mizuho reduced its target from $46 to $44 while preserving an “outperform” designation. Stifel lowered its objective from $44 to $40, retaining a “buy” recommendation. Jefferies maintains a $46 target. Wells Fargo reiterated an “overweight” stance.
Regarding insider activity, Director Harry Sloan acquired 100,000 shares at $21.85 during February—a $2.185 million investment signaling confidence in the stock’s valuation at those price levels. That purchase currently trades approximately even with prevailing market prices.
Insiders collectively have divested roughly 549,495 shares over the preceding 90 days, though they retain 47.08% ownership of the enterprise. Institutional investors hold 37.7% of outstanding shares.
The stock trades near its 52-week lows, with market capitalization approximately $10.63 billion and a beta coefficient of 1.67.
